China Resources Pharmaceutical Group Limited provided earnings forecasts for the nine months ended 30 September 2022. For the nine months, the total operating income of Jiangzhong Pharmaceutical is expected to increase by approximately 45% year-on- year, and the net profit attributable to shareholders to increase by approximately 12% year-on-year.